FDA Investigating Late Risk With Paclitaxel Balloons, Stents in PAD FDA Investigating Late Risk With Paclitaxel Balloons, Stents in PAD

Concerns about a higher risk for long-term mortality identified in a recent meta-analysis have prompted the investigation, a letter to healthcare providers notes.News Alerts

Source: Medscape Medical News Headlines - January 17, 2019 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news